Head of East Coast region at PSC Biotech which serves 350 clients in more than 23 countries worldwide through professional services consulting, cloud-based software solutions, pharmaceuticals contract manufacturing, and metrology services.

Head of Mid-Atlantic region at PSC Biotech which serves 350 clients in more than 23 countries worldwide through professional services consulting, cloud-based software solutions, pharmaceuticals contract manufacturing, and metrology services.

Led project and portfolio management software for a world-renowned biopharmaceutical organization's global network of biologics manufacturing sites. Spearheaded global product launch campaigns, including management of several contract manufacturers as well as internal supply sites.Collaborated with key stakeholders to optimize project approval, prioritization and execution strategies, while managing packaging, labeling and product serialization systems and processes.

Built business processes and tools for a leading contract research and manufacturing firm to support clinical trials for HIV. Designed and oversaw project management infrastructure, including strategy development, timeline and milestone management, and risk mitigation to ensure seamless project continuity and incorporation into the company’s larger global development planning efforts.

Oversaw global program and alliance management for a clinical stage immunotherapy company developing a natural killer cell pipeline for oncology, infectious disease and inflammatory disease indications. Led a global team, oversaw all operational activities, including detailed project plan development, technical and regulatory document creation, cross-functional meetings, key deliverable execution, and complex communications regarding metrics, updates and priorities.

Led late-stage drug development projects for a leading global pharmaceutical company in therapeutic areas, including neurology, pain and internal medicine.Managed cross-functional project management and planning for major endeavors in clinical and non-clinical stages, as well as life cycle innovation for established products.Allergan was acquired by Abbvie in 2020.

Led successful project management and clinical stage product manufacturing of cutting-edge protein therapeutics for Phase I-III clinical trials, ensuring adherence to regulatory and government contract requirements, working with CMC leaders, and effectively communicating potential project risks to key stakeholders and managing accordingly.

Managed leading-edge projects, leading cross-functional teams in pursuit of large-scale production of cell therapy-based therapeutic products, serving as key client contact for companies varying from small start-ups to government agencies to global pharmaceutical organizations, with oversight of gap analyses, feasibility assessments, quality control and quality assurance.

Managed large-scale, multimillion-dollar biopharmaceutical projects, focusing on contract testing in pre-clinical and Phase I-III trials for government, non-profit and private organizations globally, specializing in custom studies and GLP/GMP standard adherence, while working on new business opportunities.

Led biodefense and wound biology initiatives, including the pursuit of high-resolution DNA diagnostic technologies and advanced bioinformatics solutions, while retaining a secret government security clearance, working with the DoD, DHS and CDC, and using specialized training and technologies.

Designed and implemented leading-edge protocols for critical projects, including developing complex gene expression vectors, analyzing the effects and maintaining up-to-date SOPs.

Contributed to projects studying antimicrobial mechanisms.